At the 12th World Congress on Inflammation in Boston from August 8-12, Dr. Anthony Marotta will be co-chairing Symposium #29: Biomarkers in Inflammation: Focus on Rheumatoid Arthritis and will be delivering the following two presentations alongside presenter and panelist colleagues who are leaders in the field.
- 14-3-3η: A Joint-Derived Marker with Autoimmune and Personalized Medicine Applications
- 14-3-3η as a Novel RA Drug Target: Anti-14-3-3η Monoclonal Antibody Delays the Onset and Mitigates the Severity of Arthritis in CIA Mice
If you will be attending the conference, we hope to see you at these sessions. Please feel free to reply to this email to set up a meeting with Anthony for a mutual update if you are in Boston during that time.